Get our lovely INSIGHT 2019 conference news

Email address
First Name
Last Name
Interested in InSight 2019

What are you looking for?

<Good_things_happen/> Welcome to Conference

Microdosing Psychedelics: Characteristics and Correlates

Oral Presentation

Interest in the study of psychedelics such as LSD and psilocybin has resurfaced in the last decade, and while the practice of microdosing – taking sub-hallucinogenic doses – is also growing, there is a paucity of systematic research on the practice of microdosing. Objectives: Tthis pre-registered study compared between microdosers and non-microdosers using five personality, well-being, and creativity variables: Open-Mindedness, Negative Emotionality, Dysfunctional Attitudes, Wisdom, and Divergent Creativity.
We recruited an online community sample from various online forums, consisting of 909 participants (65% had microdosing experience; 82% male, median age = 26). We used the Open-Mindedness and Negative Emotionality scales of the Big Five Personality Index, Second Version (BFI-II; Soto and John 2016), the short form of the Dysfunctional Attitudes Scale for Adults (DAS-17-A; De Graaf et al., 2009), the Brief Wisdom Screening Scale (BWSS; Glück et al., 2013), and the Unusual Uses Task (Silvia, 2011). We further developed a codebook of Microdosing Benefits and Challenges based on the grounded theory analysis of 278 qualitative reports from a real-world sample of 278 microdosers.

Current and former microdosers scored lower on measures of Dysfunctional Attitudes (p &lt; 0.001, r = − 0.92) and Negative Emotionality (p = 0.009, r = − 0.85) and higher on Wisdom (p &lt; 0.001, r = 0.88), Open-Mindedness (p = 0.027, r = 0.67), and Creativity (p &lt; 0.001, r = 0.15) when compared to non- microdosing controls. In terms of qualitative findings, we found novel results, both in terms of beneficial outcomes, such as improved mood (26.6%) and focus (14.8%), and in terms of challenging outcomes, such as physiological discomfort (18.0%) and increased anxiety (6.7%). We also show parallels between benefits and drawbacks and
These findings provide promising initial evidence that warrants controlled experimental research to directly test safety and clinical efficacy. As microdoses are easier to administer than full-doses, this new paradigm has the exciting potential to shape future psychedelic Research.



September 7th 2019




Room: Rudolf Virchow
Rotem Petranker

Rotem Petranker

Psychology Department, York Unviersity, Toronto more about the speaker

Related Events

How do psychotropic drugs work?

Psychedelics challenge our current thinking of the neurobiology of psychiatric disorders, the prevailing biological treatment approaches in psychiatry and the relationship between brain function and psyche in general. This presentation will summarize the current thinking in academic psychiatry and will try to provide some future perspectives for research and clinical practice.

more details

Conference tickets

With your ticket you will have access to the whole conference - with keynotes, panels, round tables, posters and daylight social events. We will ask for a small extra fee for the Friday evening social program. The pre-conference workshops have to be booked separately and each workshop needs an individual ticket. By clicking on "Book now" below you also have the option to buy your workshop tickets.

*Reduced fees apply to students, cooperation partners as well as unemployed and retired individuals who have a monthly net income below 840,- €. Proof of status will be required.

THE CONFERENCE IS SOLD OUT! Subscribe to our newsletter to become an early bird for 2021!

Get our lovely INSIGHT 2019 conference news

Email address
First Name
Last Name